NeuroSense Therapeutics Ltd. Ordinary Shares Share Price
NASDAQ: NRSNHealthcare
Live NeuroSense Therapeutics Ltd. Ordinary Shares Share Price Chart
O H L
NeuroSense Therapeutics Ltd. Ordinary Shares Performance Overview
Days Range
▼
$6.40Low
$7.08High
Markets Today
| Previous Close | $6.72 |
|---|---|
| Open | $7.08 |
| Volume | 24,763 |
| Day's Range | $6.40 - $7.08 |
| 52W Range | $5.00 - $26.64 |
| Market Cap | $12.31 M |
Historical Performance
| 1M Returns | -15.05 |
|---|---|
| 3M Returns | -59.67 |
| 6M Returns | -58.10 |
| 1Y Returns | -73.18 |
| 5Y Returns | NA |
| 10Y Returns | NA |
NeuroSense Therapeutics Ltd. Ordinary Shares Fundamentals
| Market Cap | $12.31 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -21.75 |
| EPS TTM | $-8.73 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-11.07 M |
| Profit Margin | N/A |
| Market Cap | $12.31 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -21.75 |
| EPS TTM | $-8.73 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-11.07 M |
| Profit Margin | N/A |
NeuroSense Therapeutics Ltd. Ordinary Shares Profit & Loss
Quarterly
| Total Revenue + |
| Gross Profit + |
| Operating Income |
| EBITDA |
| Interest Expense |
| Depreciation |
| Income Before Tax |
| Income Tax Expense |
| Net Income + |
| Net Profit Margin |
NeuroSense Therapeutics Ltd. Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Share Capital | $0 | $0 | $0 | $0 |
| Reserve & Surplus | -$20.79 M | -$26.12 M | -$36.66 M | -$47.78 M |
| Non-Current Liabilities | $365.00 K | $1.49 M | $0 | $72.00 K |
| Current Liabilities | $1.73 M | $3.46 M | $1.99 M | $2.52 M |
| Total Liabilities | $2.09 M | $4.94 M | $1.99 M | $2.59 M |
| Fixed Assets | $77.00 K | $85.00 K | $66.00 K | $58.00 K |
| Current Assets | $7.38 M | $2.92 M | $4.40 M | $778.00 K |
| Total Assets | $7.71 M | $3.19 M | $4.58 M | $1.03 M |
NeuroSense Therapeutics Ltd. Ordinary Shares Cash Flow
Quarterly
| Net Income |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Change in Cash |
NeuroSense Therapeutics Ltd. Ordinary Shares Return Calculator
The NeuroSense Therapeutics Ltd. Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About NeuroSense Therapeutics Ltd. Ordinary Shares
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Popular Stocks
FAQs
What is the share price of NeuroSense Therapeutics Ltd. Ordinary Shares today?
NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) share price as of September 18, 2026 is $6.51. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of NeuroSense Therapeutics Ltd. Ordinary Shares?
Yes, Indian Investors can invest in the NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) Share by opening an international trading account with Angel One.
How can I purchase NeuroSense Therapeutics Ltd. Ordinary Shares shares in India?
Purchasing NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of NeuroSense Therapeutics Ltd. Ordinary Shares?
Yes, you can purchase fractional shares of NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of NeuroSense Therapeutics Ltd. Ordinary Shares?
The market capitalization of NeuroSense Therapeutics Ltd. Ordinary Shares on September 18, 2026, is $12.31 M.
In which sector NeuroSense Therapeutics Ltd. Ordinary Shares belongs?
NeuroSense Therapeutics Ltd. Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in NeuroSense Therapeutics Ltd. Ordinary Shares stocks?
In order to invest in NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
